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In the presence of d1.21 serum proteins, lipid dispersions
containing phosphatidyl choline and cholesterol were shown to be
effective in promoting the release of cholesterol from cultured human
fibroblasts. After incubation with these lipid dispersion-protein
complexes for 24 hours, the net cellular total cholesterol content was
reduced by nearly 50% compared.with those obtained from incubations
carried out in plain medium. The ability to promote the release of
cholesterol from cells is dependent on the presence of both lipid and
protein in the complexes. Amongst the lipids tested, cholesterol was
the only non-phospholipid that exerts a positive releasing effect.
Both cholesteryl ester and triglyceride exert anegative role.
Based on the ultracentrifugal distribution pattern of the
cholesterol released from the fibroblasts, the plausible cholesterol
acceptor complex seems to reside in the 1.063d1.21 fraction.
When the cholesterol to cholesteryl ester ratio in the
native serum high density lipoproteins were changed by the lecithin:
cholesterol acyltransferase reaction, no significant alteration of
these lipiproteins' ability to uptake cholesterol was observed. In
view of our result, the interrelationship between lecithin: cholesterol
acyltransferase and cholesterol transport remains to be established.
Combining the results of other investigators, there are
strong evidences to indicate that the serum high density lipoprotein
2
fraction is the most likely candidate responsible for the uptake and
transport of cellular cholesterol in vivo. This function of high
density lipoproteins may play an important role in the maintenance
of a constant level of cholesterol in the body cells.
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INTRODUCTION
I. HUMAN SERUM LIPOPROTEINS- COMPOSITION AND FUNCTION
Serum lipoproteins have been traditionally div:i_ded into
four classes based on their ultracentrifugal flotation properties
(Hatch and Lees, 1968 Lindgren, 1975). They are the chylmicrons, the
very low density lipoproteins (VLDL), the low density lipoproteins (LDL)
and high density lipoproteins (HDL). The lipids and apoprotein composi-
tion as well as some porperties of each of these classes of lipopro-
teins are summarized in Table 1.
The specific role of lipoprotein in lipid transport and
metabolism in the bloodstream and associated tissues is still not
clear. However, the function they played should be very important
because abnormalities of their structure and level may cause disorders
which may ultimately affect the general health of the patient. Briefly,
chylomicrons and VLDL are primarily related to triglyceride transport
and metabolism while LDL is more related to the uptake and metabolism
of cholesterol in the periphery tissue .(Morrisett et al, 1975 Brown
and Goldstein, 1976 Eisenberg and Levy, 1975 Esienberg et al, 1975).
The exact function of HDL is not yet known. It is the preferred sub-
strate for the serum enzyme lecithin: cholesterol acyltransferase
(LCAT) (Glomset, 1970 Glomset and Norum, 1973). Since the bulk of the
cholesteryl ester found in blood is derived from this enzyme reaction,
Glomset has proposed that HDL may be somehow involved in the transport
of cholesterol and cholesteryl ester from the periphery tissue to the
liver for metabolism (Glomset, 1968). Moreover, since cholesteryl ester
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Table 1. Composition and Properties of Human Serum Lipoproteins
(Ho and Chan, 1974 Trio, 1975 Morrisett et al, 1975
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45-55Proteins 1- 2 l0 25
Lipids: triglyceride 80- 90 50- 70 10 3
cholesterol 1- 3 10 8 15
5cholesteryl ester 2- 4 5 2237
3- 6 15- 20 22 30phospholipid
Carbohydrates 1 1 1
Normal level in Chinese, 94 323 151
mg/100ml.
of dry weight
6is a major component of the atherosclerotic plaques (Smith,1974), the
generation of choleste.ryl ester may be indirectly related to the
etiology of this disease.
II. REGULATION OF CELLULAR CHOLESTEROL CONTEN
The relationship between elevated serum cholesterol
level and certain disorders associated with the circulatory system,
such as atherosclerosis, is well established (Gofman et al, 1954
Smith,1974). The onset of the disease is believed to be caused by an
excessive deposition of lipids in the arterial walls. Both unesterified
cholesterol and cholesteryl esters are found to be the major constit-
uents in these deposits (Smith, 1974). The mechanism that initiates
the deposition of these lipids is still unclear. Since VLDL and LDL
are the major lipid carrier molecules in the blood, some workers
have proposed that they might be somehow involved (Zilversmit, 1976
Brown and Goldstein, 1976 Goldstein.and Brown, 1977).
It has been observed that VLDL could interact with lipo-
protein lipase on the surface of the endothelium. By the action of
lipoprotein lipase, part of the VLDL lipids, mainly triglyceride, can
be hydrolyzed and delivered into endothelium and the intima. As a
result of this infiltration process, lipid may become trapped and
deposited (Zilversmit, 1976). On the other hand, it has been found
that most of the cholesterol in the deposits is derived from plasma
7LDL (Smith,1974). Recently, Goldstein proposed that the formation of
the atherosclerotic plaque may be related to the malfunctioning of
the LDL-.receptor (Goldstein and Braion, 1.977). Thus, when the LDL level
becomes so high that it exceeds the capacity of the LDL receptors to
internalized them, additional LDL may be taken by phagocytosis. Be-
cause of this uncontrolled intake, accLu-nlation of cholesterol in the
cells of the periphery tissues may occur. As a matter of fact, Gold-
stein has proposed that the major function of the LDL receptors is to
protect against atherosclerosis. The high affinity uptake of LDL allow
the body cells to obtain sufficient cholesterol for use while at the
same time preventing the accumlation of cholesterol by turning off the
enzyme systems involved in cholesterol synthesis (Goldstein and Brown,
1977).
A number of investigators has claimed that HDL has an.
ability to remove cholesterol from cells (Goldstein,1968 Stein and
Stein, 1973 Stein et al, 1975). However, the relatioship, if any,
to the regulation of cellular cholesterol content is still far from
clear..
Owing to the importance of lipoprotein level in the
regulation of cellular lipid content, any factor that can influence
serum lipoprotein level may ultimately affect cellular lipid content.
For example, in Type II hyperlipoproteinemia, an elevated level of
serum cholesterol may be responsible for bringing about a more rapid
deposition of cholesterol in the. arterial walls (Fredrickson, 1967).
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Finally, the lost of control of de novo synthesis of cho-
lesterol within the cells may also be a potential cause for athero-
sclerosis (Brownet al, 1974 Goldstein et al) 1975).
III. OBJECTIVES OF THE PRESENT STUDY
The objective of our study is to evaluate the possible
role that lipids and HDL played in promoting the release of cholesterol
from fibroblasts. It has been observed that when dispersions of phos-
pholipid complexed to apoprotein of HDL were incubated with cultured
cells, a sizable amount of the cellular cholesterol could be released
into the medium (Stein and Stein,1973 Stein et al, 1975). A major
drawback of these results is that, in the native state, HDL or other
lipoproteins contain not only phospholi_pid but also other lipids such
cholesterol, cholesteryl ester and triglyceride. Therefore, the
possible effects, if any, of these lipids on the release of cholesterol
were not evaluated. One of our aims is to ascertain the role of these
lipids in modulating the release of cholesterol from cells and a
preliminary study on the possible involvement of an acceptor complex
for cholesterol is also included.
Finally, the possible role of LCAT in promoting cholestero:
release is also be evaluated. It has been reported that patients with
deficiency in serum LCAT activity may have many abnormalities in both
lipids and lipoproteins metabolism (Glomset and Norum, 1973). LCAT
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catalyzes the transfer of a fatty acid moiety from lecithin to choles-
terol, thus we are interested at present to investigate if the forma-
tion of cholestreyl ester by the LCAT reaction will affect the ability
of HDL to take up cholesterol from cells.
It is hoped that the results of our study will provide
a better understanding on how the lipid comositions in the serum
lipoproteins can regulate the cholesterol content of cells.
Through out the following study, dispersions of lipid
mixture containing phospholipid, cholesterol, cholesteryl ester and/
or triglyceride complexed to the d1.21 protein have been used. The
reason for choosing lipid dispersion-d1.21 protein complex rather
than serum lipoproteins as the acceptor for cellular cholesterol is
because the artifically prepared dispersions can offer a more flexible




I. METHODS IN PREPARATIVE ULTRACRNTRIFUGATTION
I.1 Preparation of Solution of Different Densities for
Ultracentrifugation
The density (d) of the ultracentrifugal medium in all our
experiments were adjusted by addition of salt similar to the procedure
used for the ultracentrifugal isolation of lipoproteins (Hatch and
Lees, 1968 Lindgren, 1975). Usually, the density of the ultracentri-
fugal medium was adjusted to either 1.006, 1.,063 or 1.21 g/ml. The
method of adjustment was.either by direct addition of solid salt or by
mixing of a higher density salt solution with the sample. The details
of these two methods are as follow:
a. Direct addition of salt
1. d=1.006 g/ml solution- Tris Saline
11.44 g NaCl (AR, Peking Chem. Co., Peking, China) and
100 mg of (ethylenedinitrilo)-tetraacetic acid disodium salt (EDTA,
AR, Mallinckrodt Inc., St. Louis, Mo.) added to 1,000 ml of 0.01 M
Tris buffer, pH 7.4.
2. d=1.063 g/ml solution
85.7 mg KBr (GR, E. Merck, Darmstadt, BRD) added to 1 ml
Tris saline or a solution of d=1.006 g/ml.
3. d=1.182 g/ml solution
62.3 g NaBr (GR, Merck) added to 250 ml Tris saline or a
solution of d=1.006 g/ml.
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4. d=1.21 g/ml solution
309.4 mg KBr added to 1 ml Tris saline or a solution of
d=1.006 g/ml.
5. d=1.474 g/ml solution
193.78 g NaBr added to 250 ml Tris saline or a solution
of d=1.006 g/ml.
b. Mixing with another solution
1. d=1.006 g/ml solution
In order to lower a solution's density to 1.006 g/ml,
the solution was dialyzed two times against 1.5 1 of Tris saline for
24 hours at 4°C.
2. d=1.063 g/ml solution
By mixing two portions of a solution of density of 1.063
g/ml and one portion of a solution of density of 1.182 g/ml. The
final density is 1.063 g/ml.
3. d=1.21 g/ml solution
By mixing two portions of a solution of density of 1.063
g/ml and one portion of a solution of density of 1.474 g/ml. The
final density is 1.21 g/ml.
1.2 Preparation of d1.21 Protein (Ho and Nichols, 1971)
Blood was clotted for 2to 3 hours at room temperature.
Serum was obtained by centrifugation at 1,500 rpm for 20 minutes.
EDTA was added to a final concentration of 0.1 mg/ml. The serum density
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was elevated to 1.21 g/ml by addition of KBr. Ultracentrifugation was
run with a 40.3 rotor at 40,000 rpm and 4°C for 24 hours in a Beckman
Ultracentrifuge (Model L5-50, Beckman Instruments Inc., Calif.).
After centrifugation, materials in the lower one third of the tube
were saved and pooled. The density of the pooled fraction was adjusted
to 1.006 g/ml by dialysis. The fraction obtained in this manner is
designated as the d1.21 protein fraction. After dialysis, the d1.21
protein fraction was heat inactivated at 60°C for 1 hour and stored
at 4°C after sterilization by filtration through millipore filter
(0.45 pm).
1.3 Preparation of d1.063 Serum Fraction
To each ml of serum, 0.1 ml of EDTA and 0.555 mg of 5,5'-
dithiobis-2-nitrobenzoic acid (DNTB, Sigma Co., St. Louis Mo.) were
added. The density of the serum was elevated to 1.063 g/ml by addition
of KBr. Ultracentrifugation was run with a 40.3 rotor at 40,000 and
40C for 24 hours. After centrifugation, materials in the lower one
third of each tube were saved and pooled. The density was then lowered
to 1.006 g/ml by dialysis. Protein concentration was determined by
Folin's method. When this fraction was analyzed by liporprotein elec-
trophoresis, it contained only a band corresponding to the high
density lipoproteins.
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1.4 Sequential Ultracentrifugation of Cell Culture Medium and Lipid
Dispersion-Protein Somplex
Under our experimental conditions the density of the cell
culture medium or lipid dispersion-protein complex was very near 1.006
g/ml, therefore, no adjustment of density is required for the first
ultracentrifugation run (with a Type 50 rotor at 40,000 rpm and 40C
for 18 hours). After the first run, materials in the top one-third
of each tube were pipetted and pooled, this fraction was designated
as the d1.006 fraction. Then the tubes were refilled with a solution
to increase the density to 1.063 g/ml. After ultracentrifugation for
24 hours under the conditions mentioned above, the top one third por-
tion of each tube was pipetted and pooled. This was the 1.006d1.063
fraction. The tubes were then refilled with a solution to increase the
final density to 1.21 g/ml and ultracentrifuged as above for 24 hours.
The top one third portion was pipetted and pooled. This was designated
as the 1.063d1.21 fraction. The middle, one third portion was dis-
carded and the bottom one third portion was pipetted and pooled. This
was the d1.21 :fraction. For the study of the radioactivity distribu-
tion pattern, the radioactivity in all fractions was assayed without
prior lowering the density to 1.006 g/ml.
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II. PREPARATION OF LIPID DISPERSION-PROTEIN COMPELX
Lipid dispersion were prepared with mixtures of choles-
terol, choelsteryl ester, triolein and egg phosphatidyl choline
(Rigma) in concentrations and molar ratios as specified in the Table
of each experiment. These lipids were used without further purifica-
tion. A known amount of lipid dissolved in chloroform was pipetted
into a conical. sonication vial. The organic solvent was evaportated
under a gentle stream of nitrogen and an exact volume of RPMI plain
medium was added to obtain the appropriate final concentration. The
mixture was sonicated in an ice-bath, under an atmosphere of nitrogen,
for 6 minutes using a Branson Sonifier (Heat System Co., Model W200R)
equipped with a standard micro-tip. The lipid dispersions thus prepared
were then incubated at.42°C overnight with an appropriate volume of
heat inactivated d1.21 protein. The form of the lipid dispersion have
not been characterized, however, by visual inspection all the lipids
appeared to be dispersed evenly in the--aqueous phase. This preparation
is designated as the lipid dispersion-protein complex. The pH of the
solution was checked after soniciation and it was within the range
for normal cell growth. All the glassware used were prewashed with
chloroform.
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III. METHODS IN CELL CULTURE (Cumming, 1970 Roth.b_lat and Cristofalo, 1972)
III.1 Preparation of Medium
RPMI 1640 power medium (KC Biological Inc., Lenexa,
Kansas) was dissolved in double dis'.tilled water according to the
instruction of the manufacturer. The solution was supplemented with
25 mM of N-2-hydroxyethylpiperazone-N`-2-ethanesul onic acid (HEPES,
Sigma) and NaHCO 3 (BDH Chem. Ltd., Poole, England). The medium so
prepared was sterilized by filtration (0.45 pm, Millipore Corp.
Bedford, MA.). Sterility was tested by incubating the filtered medium
at 370C for 2 to 3 days. For every 100 ml of medium, the following
compounds were added: 1 ml of pencillin-streptomycin solution (GIBCO,
#-514, 5,000 units pencillin G and 10,000 mcg sodium streptomycin
sulfate per ml), 1 ml of 200 mM glutamine solution (Merck), 0.05 ml
of gentamycin solution (20 pg/ml, Schering Corp.) and 0.2 ml of
mycostatin (GIBCO,# 532, 10,000 units/ml).
111.2 Preparation of Calcium and Magnesium Free Medium (CMF)
To 1 1 of double distilled water, the following compounds
were added: 0.25 g of NaH2PO4 (Merck), 0.5 g of NaHCO3 (BDH), 4.0 g of
NaCl (Peking) and 1.0 g of glucose (BDH). The solution was sterilized
by autoclaving (121°C, 1.7 kg/cm2).
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III.3 Routine Passage and Cell S toraFe
Human fibroblasts dervied from fore-skin of normal Chinese
were used. Within 36 hours after confluency the old medium was dis-
carded and the cells were detached from the cultrue bottle by incuba-
ting at 37°C with a minimum volume of 0.I% trypsin (Worthington) in
CMF for 5 to 15 minutes. The cell suspension was harvested and centri-
fugated at' 750 g for 10 minutes. The cell pellet was washed twice
with 6 to 8 ml of RPMI medium and resuspended in 5 or 10 ml of the
medium supplemented with 10% fetal calf serum (FCS, GIBCO, 11 614).
The cell number was counted in a hemocytometer.Cells were usually
plated at a split ratio of 3.
When cells were prepared for storage, they were resuspended
in a medium containing 15% FCS and 15% dimethyl sulfoxide (Merck). One
ml of the-suspension containing approximately 3 to 5 million cells was
placed into an ampule (Anug, Denmark). The ampule was first placed
at 4°C for one hour and then transferred to -20°C for another 1 to 2
hours. After.this precooling procedures, the ampule was stored in
liquid nitrogen.
For reactivation of frozen cells, cells were thawed for 30
seconds at 37°C in a water bath. Then they were pelleted by centrifu-
gation at 750 g for 10 minutes and washed .twice with warmed medium.
After the cell number and viability were determined, Cells were plated
at an appropriate concentration in either culture dish or f1ack
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III.4 Preparation of Monolayer Culture for Cell Experiment
The fibroblasts used for our cell experiment were between
the 5th and 19th passage. About 0.3 million cells suspended in 4 to
5 ml RPMI medium supplemented with 10% FCS and antibiotics were added
to.a plastic dish (40mm diameter, Falcon, Becton, Dickinson and Co.,
N.J.). For radioactivity removal study, 2 days before confluency,
0.25 pCi of 3H-cholesterol (specific activity== 8.7 Ci/rmnole, The
Radiochemical Center, Amersham, England), emulsified in 0.1 ml human
serum or d1.21 protein, was added to each plate. For cellular total
cholesterol study, no radioactive cholesterol was added.
111.5 Viability Test
111.5.1 Viability test for cells in suspension
Sterile eosin red (sigma) solution in CMF was added to a
cell suspension to a final concentration of 0.1%. Cells were incubated
at room temperature fora few minutes. The number of viable and non-
viable (ones that took up dye) cells were counted in a hemocytometer
and the percentage of viability was calculated.
111.5.2 Viability test for.-cells in mono-layer culture
After removal of the medium, 3 ml 0.1% eosin red solution
was added to the culture dish. After few minutes, the eosin red
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solution was discarded and the cell layer was inspected under an
inverted microscope. This test can not be used for the calculation of
the percentage of, viability. The purpose of the test is to ensure
there is no or only a few non-viable.cells in the culture.
IV. METHODS IN CELL EXPERIMENT
IV.1 Cell Experiment with Lipid Dispersion--Protein Complex
IV.1.1 Radioactivity removal study
Confluent monolayer fibroblast culture previously loaded
with radioactive cholesterol was washed twice with CMF. Four ml of
lipid dispersion-protein complex was then added. Cells were incubated
at 37°C in an atmosphere 95% air and 5% CO2 (tissue incubator Model
20, Shel-Lab, Sheldon Manufacturing Inc., Oregon). After 2 to 3 hours,
an :aliquot of the medium was removed and the lipids, in it were ex-
tracted. The cell layer was washed twice with CMF and cell radio-
activity was assayed as described in Section V.6.
IV.1.2 Cellular total cholesterol content study
Confluent fibroblast monolayer culture was washed with CMF
after the old medium was discarded. Four ml of lipid dispersion-
protein complex were added to the dish and the cells were incubated
at 37°C in a CO2 incubator for 24 hours. After incubation, the medium
was aspirated and cell lipid was extracted as described in Section
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V.7. The cholesterol content of the extract was determined by gas
liquid chromatoaraDhv.
IV.2 Cell Experiment with d1.063 Serum Fraction
Mercaptoethanol was added to the d1.063 serum fraction con-
taining DTNB (an inhibitor of the enzyme lecithin: cholesterol
acyltransferase) to a final concentration of 0.0118 M. After mixing,
the fraction was incubated at 37°C in a shaking water bath. Aliquots
of the d1.063 serum fraction.were removed at 0, 1, 3, 6 and 24
hours and were chilled in an ice-bath immediately. The solutions were
firstly dialyzed against Tris saline containing 0.1% mercaptoethanol
then against plain Tris saline. All dialyses were performed at 4°C.
After dialysis, the d1.063 serum fractions were heat inacti-
vated at 60°C for 1 hour. The final protein concentrations were
determined and the concentration of the protein in each fraction was
adjusted to the value of serum (76 mg/ml). These preparations were
sterilized by filtration through millipore filters (0.45 um) and
aliquots were saved for chemical analyses of cholesterol and choles-
teryl ester content. In'the final experiment, cells were incubated
in RPMI medium containing 10% of these incubated d1.063 serum
fractions.
Confluency fibroblast monolayer culture was washed twice with
CMF after the old medium was discarded. Then 4 ml incubation medium
containing the d1.063 serum fraction were added. Cells were incubated
at-37 0 C in a CO. incubator for 24 hours. After incubation, the medium
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was aspirated and the cellular total cholesterol content was determined
as described in Section V.7.
V. ANALYTICAL METHODS
V.1 Protein Concentration Determination Folin's Method (Lowry et aZ,
1951)
Aliquots of samples containing 25 to 200 pg protein were
adjusted to a final volume of 0.25 ml. Two and a half ml of Reagent B
were then added and the contents mixed. After ten minutes, 0.25 ml
of Reagent A was added and mixed immediately. Absorbance was read
at 750 nm after the solutions have been standing at room temperature
for 30 minutes. Protein standard of the following concentrations,
0.025, 0.050, 0.100 and 0.200 mg/ml, were prepared by dissolving
crystalline bovine serum albumin (Sigma) in water.
Reagent B was prepared by mixing 2 ml 2% CuSO4.5H20 solution
with 2 ml 4% potassium tartarate solution. The mixture was diluted to
100 ml with 3% Na2CO3 in 0.1 N NaOH. Reagent A was Frepared by
diluting Folin and Ciocalteu's Phenol Reagent (BDH) with water
(1:1, v/v).
V.2 Total Lipid Extraction and Fractiontion
V.2.1 Extraction
The methods used was a modified form of the one used by
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Sperry and Brand (1955).
One ml sample was placed in a 40 nil vial, 8.5 ml of methanol
and 8.5 ml of chloroform were then added. The vial was capped, swirled
gently, and placed in a 700C water bath for 20 minutes with swirling
every 3 of 4 minutes. After cooling, the volume was adjusted to 25 ml
with chloroform. The contents were then filtered with prewashed filter
papers and 20 ml of the filtrate were collected. Five ml of water
were added to the filtrate and the contents shaken vigorously for 1
minute. The aqueous and organic phases were separated by centrifugation
at 1,000 rpm for 5 minutes. The top layer was discarded. Three ml of
Sperry Wash' were layered on top of the organic phase and the content
of the vials were mixed, The upper phase was removed after centrifu-
gation, and the organic phase blown down by a gentle stream of nitrogen.
All glassware and filter papers used in the. extraction were prewashed
with chloroform.
V.2.2 Fractionation
Lipid extracts were dissolved in minimum volume of chloro-
form and fractionated by thin layer chromatography (5 x 20 cm, Silica
Gel 1B, Backer Chemical Go., Philadelphia., Penna.). Plates were
developed in either one of the following solvent systems: petroleum
ether: diethyl ether: glacial acetic acid (85: 15: 3 v/v)
hexane: diethyl ether.: glacial acetic acid (60: 40: 1 v/v).
After exposure of the plates to.iodine vapor, areas corresponding to
cholesterol and cholesteryl ester or other lipids were identified
Please refer to the footnote on page 22.
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by comparing with known standards. The areas correspinding to a
particular lipid was scrapped and the lipid eluted by treatment
with 5 ml of chloroform: methanol (2: 1 v/v) twice. The quantities
of these purified lipids were determined by analytical methods as
described below.
V.3 Total Lipid Determination (Kritchevsky et aZ, 1973)
Aliquots of total lipid extracts containing no more than
100 pg of lipids were placed in test tubes prewashed with chloroform.
The organic solvent was evaporated under a gentle stream of nitrogen.
Standards ranging from 0 to 200 jig were prepared from olive oil
(Sigma). Two ml concentrated H2SO4 were added to each tube and the
tubes were placed in a boiling water bath for 20 minutes. After the
tubes were cooled by running water for 1 minute, they were placed in
an ice-bath for 5 minutes, Three ml of water were then added. After
mixing the tubes were placed in an ice-bath for 10 minutes. Absorbance
was read at.375 nm after the samples had been equilibrated at room
temperature.
V.4 Colorimetric Determination of Cholesterol and Cholestery
Ester (Leffler, 1959)
Sperry Wash was prepared by mixing of 96.3 ml of chloroform:
methanol (2:1 v/v) and 23.7 ml of 0.02% CaCl2 solution, the upper
aqueous phase was used after the organic and aqueous phases had been
separated completely.
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One ml of a properly diluted sample was pipetted into a screw
cap culture tube. Standards containing 0.2, 0.1, 0.05, 0.025 or 0.0125
,g/ml of cholesterol or cholesteryl oleate (Sigma) were prepared. Two
ml of glacial acetic acid were added and the tube was mixed immediately.
Two ml of a freshly prepared color reagent* were dispensed carefully
into the tubes so that the final mixture separated into 2 layers. The
tubes were capped and the contents mixed by inverting four times. After
exactly 10 minutes, absorbance was read at 540 nm.
V.5 Lipoprotein Electrophoresis-(Noble,1968 Narayan, 1975)
Agarose (Sigma) gel, 0.75% in 0.0125 M barbital buffer,
pH 8.6, was coated on 1 x 3 in. plastic slides with 3 channels (Bio-
Rad Lab., Richmond, CA.). The slides were soaked in 0.5% albumin
barbital buffer for at least 24 hours before use. Samples were applied
after the slide surface was moderately dried in air. Electrophoresis
was performed at a constant voltage of 150 volts. The buffer in the
two electrode compartments was 0.025 M barbital buffer, pH 8.6.
After electrophoresis, the gels were fixed for two 15 minute periods
in a solution of ethanol': glacial acetic acid: water (12: 1: 7
v/v). The gels were then stanined for 15 minutes in a Fat Red stain-
The color reagent was prepared by diluting 8 ml of an iron stock
solution (2.5 g of FeCl3.6H,O in 100 ml 87% phosphoric acid) to
100 ml with concentrated H,,20,.
24
ing solution*. Slides were destained by soaking firstly. in 70% methanol
for 25 minutes and then in 2% glycerol for 5 minuted. Afterwards, the
slides were flushed with running water for 20 minutes. They were dried
under a gentle stream of warm air from a hair dryer.
V.6 Radioactivity Assay
V.6.1 Medium radioactivity assay
To each ml medium 1 ml absolute methanol was added. Radio-
activity was extracted twice with 2 ml of hexane. 0.5 mg of cholesterol
was added into the extraction mixture as carrier. The hexane extracts
were pooled and dried under a gentle stream of nitrogen. Lipids were
fractionated by thin layer chromatography as described in Section V.2.
The areas corresponding to cholesterol was cut and placed in a
scintillation vial. Severn ml of a toluene-base scintillation fluid**
were added and the radioactivity of the samples was counted in Beckman
LS-330 Liquid Scintillation Counter. The error of our counting proce-.
dure was preset to 1% at 95% confidence level.
Fat Red 7B staining solution was prepared freshly by adding 4 drops
of trition X-100 (Ajax Chem., Sydney) to 100 ml of stock stain
solution followed by addition of 20 ml of 0.1 N NaOH solution.
Stock stain was prepared by dissolving 0.45 g of Fat Red 7B (Sigma)
in 2 1 of absolute methanol.
The toluene-base scintillation fluid was prepared by dissolving 4 g
of 2,5-diphenyloxazole and 0.4 g of 2,2'-p-phenylene-bis-(5-phenyl-
oxazole) in 1 1 of toluene (Ajax).
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V.6.2 Cell radioactivity assay
After the cell layer was washed, cells were scrapped into a
glass centrifuge tube with the aid of 2 ml 50% methanol followed by
3 ml 100% methanol. After the addition of 4 ml of chloroform containing
0.5 mg cholesterol, samples were extracted overnight under an atmo-
sphere of nitrogen. The insoluble materials in the extract were pelleted
by centrifugation at 3,000 rpm for 20 minutes. After removing the
organic solvent, the amount of protein: in the pellet was solublized in
1 N NaOH for 1 to 2 days. The protein content in the pellet was deter-
mined by Folin's method. The chloroform/methanol extract, containing
the cell lipids, was washed and fractionated on TLC plate as described
in Section V.2. The area corresponding to cholesterol was cut and placed
into a scintillation vial. Counting was done as described above.
V.7 Determination of Cellular Total Cholesterol by Gas Liquid.
Chromatography (Ishikawa et at, 1974)
Cells were scrapped into a glass centrifuge tube with the
aid of 2 ml 50% methanol-followed by 3 ml 100% methanol. After the
addition of 4 ml of chloroform, samples were extracted overnight under
an atmosphere of nitrogen. Insoluble materials in the extract were
pelleted by centrifugation at 3,000 rpm for 20 minutes. After removing
the organic solvent, the amount of protein in the pellet was determined
as described in the previous section. To the chloroform/methanol
extract, 40 ua of 5a-cholestane(Si2ma) in chlnrnfnrm were added at
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internal standard. The extract was then washed and evaporated to
dryness under a gentle stream of nitrogen. The lipid residue was
hydrolyzed according to Ishkawa's procedure.
Tetramethylammonium hydroxide/isopropanol solution was
prepared by adding 100 ml of isopropanol to 25 ml of a 24% methanolic
solution of tetramethylammonium hydroxide (Sigma). 100 pl of this
solution were added to the test tube containing the lipid to be
hydrolyzed and the mixture vortexed for 5 seconds. Solutions were
then heated for 15 minutes at 80°C in a water bath. After cooling for
30 seconds in an ice-bath, 50 pl of a solution of tetrachloroethylene/
methylbutyrate (1:3 v/v) (Tokyo Kasei, Japan) were added and mixed
immediately. After the addition of 200 pl of water, the mixture was
vortexed for 15 seconds and centrifuged at 2,000 rpm for 10 minutes.
Two to 3 pl of the clear lower phase were injected into a gas liquid
chromatography (Varian, Series 3700, Palo Alto, CA.) equipped with
a flame ionization detector. For quantitation of cholesterol, a stainless
steel column (1 m x 2 mm) packed with 3% SP-2250 on 100-200 mesh Gas-
Chrom Q.(Supelco Inc., Bellefonte, Pa.) was used. Temperatures for
the column, the injection port and the detector were set at 250°C,
290°C and 300°C respectively. The flow rate of the carrier gas was
approximately 300 ml/minute. The efficiency of the column was monitored
by control samples containing known amounts of 5a-cholestane and
cholesterol. Before the injection of samples, the column was always
primed with 20 pg of cholesterol and 5a-cholestane.
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RESULTS
I. EFFECTS OF LIPID COMPOSITIONS IN PROMOTING THE RELEASE OF
CHOLESTEROL FROM FIBROBLASTS
I.1 The Effect of Cholesterol and. Cholesteryl Ester
The reason for choosing cholesterol as the first kind
of lipid for study is because of its importance in many disorders
associated with the circulatory system, For example, the lipid
deposited in the atherosclerotic plaque is mainly cholesterol
(Smith, 1974). And that this molecule is the substrate of LCAT
which is an enzyme in the serum thought to be intimately associated
with cholesterol and lipoprotein metabolism (Ho, 1975,Glomset, 1973)
Lipid dispersion-protein complexes were prepared as
described in Materials and Methods (Section II). Their compositions
are summarized in Table 2. In general, sonicated lipid dispersions
containing various proportion of lipids were mixed with heat
inactivated d1.21 protein fraction and incubated at 420C over-
night. The amount of radioactive cholesterol released was determined
as described in Materials and Methods (Section V) and the results
obtained are presented in Table 2.
As indicated, all sonciated preparations of different lipid
compositions possessed the ability to promote the release of radio-
active cholesterol. Compared with the protein blank, the amount of
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Table 2. The effect of different cholesterol to cholesteryl ester
ratio in promoting the release of radioactive cholesterol
form fibroblasts.
Cultured fibroblasts were incubated for 3 hours
at 37C with 4 ml of various lipid dispersion-protein
complex as described in Materials and Methods. The
final concentration of d1.21 protein was 30 mg/m1.
The final concentration of lipid was 0.38 mM for egg
phosphatidyl choline and 0.26 mM for total cholesterol.
The protein blank contained only d1.21 protein, and
the medium blank contained no lipid dispersion and
d1.21 protein. The molar ratio of cholesterol to
cholesteryl ester in each complex was indicated in the
table. The radioactivity in the cells plus the radio-
activity removed into the medium was served as 100%
for the calculation of the precentage of cellular
radioactive cholesterol rc1 easc. The cel1 Viability
was checked by Eosin Red exclusion before and after
inctjation. Values are means+ standard deviations.
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Table. 2.







10.68+ 0.53protein d 1.anx
5.28+ 0.52medium blank
The abbreviations. used were: UCS, unesterified cholesterol and CSE, cholesteryl
ester.
sF'c This complex containing no cholesterol and only egg phosphatidyl choline and
d1.21 protein.
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radioactive cholesterol released was si.gniticantly nigner in the
presence of lipid. The highest rate of radioactive cholesterol
release was associated with the dispersion containing only cholesterol
and phosphatidyl choline. The presence of cholesteryl ester tended
to impair the ability of the dispersion to promote the release of
radioactive cholesterol. However, increasing the molar ratio of
cholesteryl ester to cholesterol, did not enhance impairing effect
further. Based on these results, it is evident that the substitution
of cholesteryl ester for cholesterol may have a negative effect on
the ability of a phospholipid cholesterol dispersion to promote
the release of cholesterol from fibroblasts. Apparently, this effect
only depends on the presence of cholesteyl ester, and is not
critically related to the ratio of cholesterol to cholesteryl
ester.
The effect of either cholesterol or cholesteryl ester
alone in promoting the release of radioactive cholesterol from
fibroblasts was tested in the next set of experiments. These experi-
ments were carried out under conditions identical to those described
in Table 2 and Materials and Methods. The lipid compositions of the
dispersions and the results are presented in Table 3.
As we have previously demonstrated the presence of lipid
significantly promoted the release of radioactive cholesterol. This
promoting effect appears to be independent of the cholesterol and
cholesteryl ester content, since phosphatidyl choline alone was
able to promote a similar magnitude of radioactive cholesterol
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Table 3. The effect of different cholesterol or cholesteryl
ester concentration in promoting the release of radio-
active cholesterol from fibroblasts.
Cultured fibroblasts were incubated for 3 hours
at 370C with various lipid dispersion-protein complexes
as described in Materials and Methods. The final con-
centration was 30 mg/ml for d1.21 protein and 0.38 r1M
for egg phosphatidyl choline. The molar concentration
of cholesterol or cholesteryl ester in each complex was
as indicated in the table. The protein blank contained
only the d>1.21 protein, and the medium blank contained
no lipid dispersion and d1.21 protein. The radio-
activity in the cells plus the radioactivity removed
into them.edium was served as 100% for the calculation
of the precentage of cellular radioactive cholesterol
release. The cell viability was checked by Eosin Red




Cellular radioactive cholesterol release(4)Molar concentration of
UCS or CSE (mM)






10.2 -e 0.42 10.2+ 0.42protein blank
4.7+ 0.144.7 0.14medium blank
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When, the rate of release was compared amongst the dispersions
containing different ratios of cholesterol and. cholesteryl ester,
no pronounce difference could be detected.
On the other hand, compared with results listed in Table 2,
there is a disagreement. Dispersions containing the same amount of
choles eery l ester showed quite a large difference in the rate of
release of radioactive cholesterol. (26% vs. 18%). Unfortunately, we
cannot offer a good explanation on this at the moment.
1.2 The Effect of Triglyceride Substitution
In view of the fact that triglyceride and cholesteryl
ester are believed to play an interchangable role in the formation
of the apolar core of serum lipoproteins (Morrisett et 'al, 1977),
the following experiment was performed to ascertain if the sub-
stitution of cholesteryl ester triglyceride will affect the ability
of our dispersion to release radioactive cholesterol from the
cells. The composition of the lipid dispersion-protein complexes
and the results obtained are shown in Table 4.
From the results presented in Table 4, an increase amounts
of triglyceride substitution in the lipid dispersion tends to
reduce the amount of radioactive cholesterol that can be released
into the medium. Based on these results, it is likely thst super-
imposed on the regulatory effect of cholesterol and cholesteryl
ester, triglyceride may further confer a persumbly negative effect.
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Table 4. The effect of triglyceride substitution tor ct olesteryl
ester in promoting the release of radioactive cholesterol
from fibroblasts.
Cultured fibroblasts were incubated for 3 hours or 2
hours at 370C with various lipid dispersion-protein complexes.
The final concentration was 30 mg/ml for d1.21 protein,
0.38 mll for egg phosphatidyl choline and 0.065 mM for
cholesterol. The molar ratio of cholesterol, cholesteryl
ester and triglyceride was as indicated. The protein blank
contained only the d1.21 protein and the medium blank
contained no lipid dispersion and d1.21 protein. Radio-
activity in the cells plus that removed into the medium was
taken as 100% for the calcualtion of the precentage of
cellular radioactive cholesterol release. Cell viability was
checked by Eosin Red exclusion before and after incubation.
Values are means+ standard deviations.
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Tab 1 e 4.
Cellular radioactive cholesterol release(%Molar ratio of UCS/CSE/TGx
experiment 2**experim 'nt 1*
16.4+ 0.423.4± 0.61/ 3/ 0
13.3+ 0.623.0± 4.11/ 2/ 1
9.8+ 2.121.5± 0.71/ 1/ 2
8.2+ 1.819.4± 2.01/ 0/ 3
13.9+ 0.422.6 41- 1.8D/ 0/ 0'
9.2+ 0.810.2± 0.4protein b±anx
8.4+ 0.44.7±0.1medium blank
The abbreviations used were: UCS, unesterified cholesterol CSE, cholesteryl
ester TG, triolein.
The incubation period for experiment 1 was 3 hours and for experiment 2 was
2 hours
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1.3 The Effect of Lysophosphatidyl Choline Substitution
As indicated in Tables 2 to 4, the precentage of radio-
activity removed in the presence of phosphatidyl choline alot.e.w.as
quite high and comparable to those in the presence of cholesterol
and cholesteryl ester. This observation is agreeable with the
results obtained by Stein and Stein and their colleagues (Stein and
Stein, 1973 Stein et al, 1975). In their experiments, they demon-
strated that s.onicated mixtures of phospholipids and apoprotein of
HDL could increase the rate of cholesterol removal from ascites
cells.
Since lysophosphatidyl choline is one of the by-products
of the LCAT reaction (Glomset, 1968), we are interested to determine
if the substitution of this lipid for phosphatidyl choline will
affect the ability of the dispersion to release radioactive
cholesterol from the cells. The composition of the lipid dispersion-
protein complexes that we have used and the results obtained are
summarized in Table 5.
As indicated, substitution of lysophosphatidyl choline for
phosphatidyl choline was ineffective in altering-the rate of radio-
active cholesterol significantly. Hence, compared with cholesteryl
ester, this by-product of the LCAT reaction does not seem to play a
crucial role in regulating the release of cholesterol.
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Table 5. The effect of substitution of lysophosphatidyl choline
for phosphatidyl choline in promoting the -release of
radioactive cholesterol from fibroblasts.
Cultured fibroblasts were incubated for 3 hours
at 370C with lipid dispersion-protein complex as
described in Materials and Methods. The final concen-
tration of lipid was 0.38 mM for phosphatidyl choline
0.065 mM for cholesterol and 0.195 mM for cholesteryl
ester. The molar ratio of phosphatidyl choline to
lysophosphatidyl choline in each complex was indicated
in the table below. The protein blank contained
d1.21 protein only and the medium blank contained
no lipid dispersion and d1.21 protein. Radioactivity
in the cells plus that removed into the medium was
taken as 100% for calculation of.the precentage of
cellular radioactive cholesterol release.* Cell
viability was checked by Eosin Red exclusion










The abbreviations used were: PC, phosphatidyl choline and LPC, lysophosphatidyl
choline.
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1.4 The Effect of d1.21 Protein
In order to examine whether the d1.21 protein fraction is
required together with the lipid dispersion to promote the. release
of radioactive cholesterol, the following experiment was performed.
Cells were incubated with media containing (1) a lipid dispersion-
protein complex, (2) d1.21 protein only, (3) lipid dispersion only
and (4) medium only. The rate of radioactive cholesterol released
was determined as previously described. Table 6 summarizes the
details and the results of this experiment.
As indicated in Table 6. the absence of either d1.21
protein or lipid dispersion reduces the amount of radioactive
cholesterol released by about 50%. This result suggests strongly
that the cooperation between the. d1.21 protein and lipid dispersion
is important and it is likely that the formation of an effective
complex between the proteins and the lipid is required for optimal
release of cellular cholesterol.
II. STUDY ON THE POSSIBLE MECHANISM INVOLVED IN THE: RELEASE OF
RADIOACTIVE CHOLESTEROL FROM FIBROBLASTS
The appearance of radioactive cholesterol in the culture
medium as observed in the above experiments can be due to either an
exchange process or a net removal mechanism. The difference between
this two phenomena is that the first one does not chance the
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Table 6. The effects of lipid 'and/or: protein in promoting the
release of radioactive cholesterol from fibroblasts.
Cultrued fibroblasts were incubated for 3 hours at
37 o C with various constituents in the medium. With the
presence of d1.21 protein, the final concentration was
30 mg/ml. For lipids, the final concentration was 0.38 mM
for phosphatidyl choline, 0.065 mM: for cholesterol and
0.195 mM for cholesteryl ester. The detail compositions
is as indicated. The protein blank contained only d1.21
protein and-the medium blank contained no lipid dispersion
and protein. Radioactivity in the cells plus that removed
into the medium was taken as 100% for calculation of the
percentage of cellular radioactive cholesterol release.
Cells viability was checked by Eosin Red exculsion before
and after incubation. Valies are means +standard deviations.
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Table 6.
Cellular radioactive cholesterol release(%Constituents in medium
15.24+ 1.37lipids+ d1.21 protein
8.39+ 0.16lipids only
8.10+ 0.30d1.21 protein only
4.70+ 0.10medium blank
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cellular total cholesterol content while the second one reduces the
cellular total cholesterol content. To resolve this problem, the
following experiment was performed.
Lipid dispersion-protein complexes were prepared according
to the composition specified in Table 7. After incubation at 4200
overnight, the lipid dispersion-protein complex was added to fibro-
blasts monolayer culture without previously loading the cells with
radioactive cholesterol. After incubation for 24 hours at 370C,
the cellular total cholesterol content was determined by gas liquid
chromatography. The results obtained are presented in Table 7.
As indicated in Table 7, compared with the control medium
blank, all cultures incubated in the presence of lipid dispersion-
protein complex exhibited a 20-- 50% decrease in the total
cholesterol. Combining with the results shown in Table 2, these
results suggest that the mechanism by which the lipid dispersion-
protein complex promotes the release of radioactive cholesterol fror
fibroblasts is due to net removal rather than exchange.
On the other hand, the lowest cellular total cholesterol
content was associated with. the incubation carried out in the
presence of the d1.21 fraction only. Cultures incubated in the
presence of lipids had in general higher cellular total cholesterol
content. Based on these results, it is likely that there is a
simultaneous uptake of cholesterol into the cells from the lipid
dispersion-protein complex. 1-loc rever, it is possible that uptake
is slower than the rate of removal and as a result, there was
still a net reduction of cellular cholesterol content.
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Table 7. The cellular total cholesterol content of fibroblasts
after incubation with various lipid dispersion-
protein complexes.
The final concentration of .d >1.21 protein was 30 mg/ml.
The final concentration of lipid was 0.38 mM for phospha-
tidyl choline and 0.26 mM for total cholesterol. The molar
ratio of cholesterol to cholesteryl ester in each complex
was as indicated. The protein blank contained only the
d1.21 protein and the medium blank contained no lipid
dispersion and d1.21 protein. After incubation for 24 hours
at 370C, the old medium was discarded and the cellular
total lipid extracted and hydrolyzed as described in
Materials and Methods. The total cholestreol content was
determined by gas liquid chromatography. Before the
termination of the incubation, viability of the cells was
determined to be satisfactory. The cholesterol -.content
was calculated by comparing the peak height ratio of
5a-cholestane with those of mixtures containing known




Cellular total cholesterol contentMolar ratio of UCS/CSE





0/ 1 56 55+ 1.6
46.53 +11.8protein blank
medium blank 95.82 +10.8
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In view of the above reasoning, the mechanism mediated by
lipid dispersion-protein complex to promote cholesterol release is
better described as net removal with a partially compensated re-
entrance of cholesterol. The magnitude of this compensation process
is apparently depended on thb. amount of cholesterol present in the
incubation medium.
III. ULTRACENTRIFUGAL DISTRIBUTION OF RADIOACTIVE CHOLESTEROL
RELEASED INTO THE MEDIUM
Cholesterol, after removal from the fibroblasts, cannot
be by itself suspended in:the outside aqueous medium. It has to be
solublized by complexing with proteins or lipid dispersion-protein
complexes. The aim of the experiments described in this section is
to ascertain the distribution of the radioactivity released into
the medium by ultracentrifugal flotation.
Lipid dispersion-protein complexes were prepared accordinhg
to Table 8. After incubating with the cells for 3 hours, the medium
was removed and subjected to sequential ultracentrifugal flotation
at d=1.006, d=1.063 and d=1.21. Fractions flotated at different
density intervals were extracted with hexane and the radioactivity
counted as described in Materials and Methods. The results are
presented in Table 8.
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Table 8. Distribution pattern of radioactive cholesterol
released into the medium.
Cultured fibroblasts were incubated for 3 hours
at 37°C with various lipid disper sion protein complexes.
The final concentration of lipid was 0.38 mM for egg
phosphatidyl choline and 0.26 mM for total cholesterol.
The molar ratio of cholesterol to cholesteryl ester
is as shown in the table. The final concentration of
d1.21 protein was 30 mg/ml. After incubation, the
medium was removed and subjected to sequential ultra-
centrifugation as described in Materials and Methods.
Fractions were then extracted with hexane and the
radioactivity in the hexane extracts assayed. The
distribution of radioactivity is expressed as the
percent of radioactivity in the entire tube. Cell.
viability was checked by Eosin Red exclusion before





d1..006.' 1.006d1.063 1.063d1.21- 1.21dMolar ratio or uU5/Ub
8.15+0.8215.16+3.0175.24+3.061/ 0 1.41+0.72
15.55+1.403/ 1 1.33+0.17 6.43+0.0676.7--1.29
1/ 1 19.84+1.591.84+0.94 71.2±2.45 7.12+1.80
2.05+0.91 16.98+2.48 7.78+0.621/ 3 73.18+0.87
0/ 1 2.44+0.20 64.26+4.90 23.49+4.10 9.81+1.00
protein blank 4.01+0.85 25.81+0.07 16.93+0.09 53.26+1.01
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As indicated in Table 8, the distribution patterns of
radioactivity are similar even though dispersions containing different
lipid mixtures were used for incubation. In general, about 72% of
the radioactive cholesterol released was associated with the
1.006d1.063 fraction while only 18% was associated with the higher
density 1.063d1.21 fraction. Fractions of densities less than
1.006 and greater than 1.21 contained only 2% and 8% of the
total radioactivity released. In contrast to the above results,
when the incubation was carried out in the presence of the d1.21
protein alone (protein blank of Table 8), the distribution pattern
of radioactivity was totally different. Half of the radioactivity
was in the. d1.21 fraction and only 25% was associated with the
1.006d1.063 fraction. Based on these results, it is apparent that
the pattern of radioactive cholesterol released is independent of
the cholesterol to cholesteryl ester ratio of the complexes but
dependent only on the presence of lipid.
In the next experiment, we are interested to compare the
distribution pattern of radioactive cholesterol before and after
incubation with cells and results are summarized in Table 9.
Comparison of the two distribution patterns, there is a
moderate shift of the radioactivity to the higher density fraction
after incubation with the cells. This shift can be accounted for
in at least two ways. First, a redistribution of cholesterol after
incubation has occurred and this may due to an increased level of
cholesterol since some cholesterol had been removed from cells.
Second, the cholesterol removed from the cells preferably may
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complexed with the higher density fraction. By an equilibration
process the radioactivity may be redistributed to other density
fractions according to their relative cholesterol contents. Since
the higher density fraction is involved in the uptake of cholesterol
from the cells, its relative cholesterol content will increase. As
a result the relative precentage of radioactivity associated with
it will increase accordingly. Based on our data, the 1.063d1.21
fraction is probably the fraction responsible for the uptake of
cholesterol from the cells. This is so, because the radioactive
content of this fraction increased by about 70% before and after
incubation. In veiw of the above reasons, the 1.063d1.21 fraction
is probably the cholesterol acceptor.
IV. EFFECT OF HIGH DENSITY LIPOPROTEIN (HDL) IN PROMOTING THE
RELEASE OF CHOLESTEROL FROM FIBROBLASTS
in all the experiments described so far artifical lipid
dispersion-protein complexes were used as the vehicle for cholesterol
uptake. When these dispersion complexes were fractionated by
sequential ultracentrifugal flotation, supporting evidence was
obtained indicating that the 1.063d1.21 fraction may be the
cholesterol acceptor..
It has been reported by Stein and Stein that HDL possess
a higher ability to promote the release of cholesterol from cells
than LDL (Stein and Stein, 1973 Stein et al, 1975). Further
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experiments by these workers showed that phospholipid dispersions
complexed to the apoprotein of HDL or to purified apoproteins
have similar ability to the release of cholesterol (Jackson et al,
1975). But as mentioned in the Introduction, the possible role of
other lipds has not been evaluated in these studies. In the
experiments described in the previous sections we have shown that
both cholesteryl ester and triglyceride have a negative effect on
the release of cholesterol. Because of this, we have designed an
experiment to evaluate if, by altering the cholesterol to cholesteryl
ester ratio in HDL, a change in the ability of this lipoprotein to
uptake cholesterol will result.
The cholesterol to cholesteryl ester ratio of HDL can
be changed by the LCAT reaction. Thus, by incubating HDL with LCAT
for different periods, HDL fractions contain different cholesterol
to cholesteryl ester ratio can be obtained. Since it i,4 impossible
to obtain HDL totally lack of cholesteryl ester, the ability to
vary the cholesterol to cholesteryl ester of these natural lipo-
proteins cannot be as flexible as that of the lipid dispersion-
protein complex. During the incubation with LCAT, the lecithin to
lysolecithin ratio. will also changed. Since we have demonstrated
that lysolecithin is not critical in affecting the release of
cholesterol from cells, the role of this lipid will not be con-
sidered in the present experiment.
Aliquots of d1.063 serum fraction consisting of HDL
and most of the serum LCAT activity (Ho and Nichols, 1971) were
incubated for different periods as described in Materials and
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and Methods. Lipids in the medium were extracted and the cholesterol
to cholesteryl ester ratio determined. Cells were incubated with the
d1.063 serum fractions for 24 hours and were collected for
cholesterol content determination. The results obtained are presented
in Tab le 1O.
Since cholesterol was continuously esterified by the
action of LCAT, the cholesterol to cholesteryl ester molar ratio
of the different HDL preparations decreased, as expected, propor--
tionally with the incubation time. When these HDL fractions were
incubated with the cells, the cellualr total cholesterol content was
not significantly different from each other. Nevertheless, compared
with the medium blank, there was a 25 rti 40% decrease. This indicates
that HDL shares the same ability as the lipid dispersion-protein
complex system in promoting the release of cholesterol from fibro-
blasts.
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Table 9. Comparsion of the distribution patterns of radioactive
cholesterol. in lipid. dispersion-protein complex
before and after incubation with cells.
Trace amounts of radioactive cholesterol was
added to the lipid mixture, after sonication and
comp lexin g to d>1.21 protein, the complex was frac-
tionated by sequential ultracentrifugation as des-
cribed in Materials and Methods. Other coniditions are
as in Table 8.
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Table 9.






The molar ratio of cholesterol: cholesteryl ester: phosphatidyl choline in
the lipid dispersion is 1: 3: 6.




Cellular total. cholesterol contentIncubation period of
UCS /CSE








Table 10. The cellular total cholesterol content of fibroblasts after
incubation with various d1.063 serum fraction preparations.
The d1.063 serum fraction was prepared and incubated with
mercaptoethanol as described in the text. After incubation
for 24 hours at 370C with cells, the old medium was discarded
and the cellular total lipid extracted and hydrolyzed. The
total cholesterol content was determined by gas liquid
chromatography. Before the termination of the incubation,
viability of the cells was determined to be satisfactory.
The cholesterol content was calculated by comparing the peak
height ratio of 5a-cholestane with those of mixtures containing
known. amounts of cholesterol and 5a-cholestane.
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DISCUSSIONS
Lipoprotein and. its relationship to lipid metabolism and
certain pathological disorders have been extensively investigated
during the past decade. Many studies have been carried out on lipo-
protein structure and metabolism (Ho, 1975 Eisenberg and Levy, 1975
Eisenberg et al, 1975 Jackson et al, 1976 Morrisett et al, 1977),
as well as on the possible relationship between lipoprotein and diseases
such as atherosclerosis (Gofman, 1954 Smith, 1974 Zilversmit, 1976
Goldstein and Brown, 1977). As mentioned in the Introduction, athero-
sclerosis is caused by the deposition of lipid, especially cholesterol,
in the arterial wall, The wei l-known L DL receptor, ddiscovered by
Goldstein and Brown, is believed to le one of the mechanisms by
which the cell ultilizes to maintain a constant level of cholesterol.
The malfunction of this receptor may bring about an excess deposition
of cholesterol leading to the development of atherosclerosis (Goldstein
and Brown, 1977),
In addition to the LDL receptor, another type of mechanism
based on the work of Stein's group (Stein and Stein, 1973 Stein et al,
1975 Jackson et al, 1975) may also playa cruical role in the main-
tenance of a constant level of cholesterol in the cell. They found
that HDL as well as certain artifical preparations of apoprotein of
HDL and phospholipid have the ability to remove cholesterol from
cells in culture. Thus, they proposed that these macromolecular
complexes may be responsible for channeling excess cholesterol from
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the cells back into the blood stream.
The present work was undertaken to evaluate the role of other
lipids besides the phospholipids' in modulating the release of
cholesterol from cells. Based on the results presented in Tables
1 to 8, it is apparent that the lipid dispersion-protein complexes,
prepared according to our methods, was effective in promoting the
release of cholesterol from cells. This ability depends on both the
presence of lipids and the d1.21 protein. Absence of either one may
impair the ability of the other to promote the release of cholesterol
treatly. However, the lipid composition of these complexes is
important. Complexes containing only cholesterol and phosphatidyl
choline had the highest ability to promote the release of Cholesterol,
and substitution of cholesteryl ester for cholesterol may impair
this ability. Replacement of cholesteryl ester by triglyceride
produces further impairment of cholesterol uptake by the lipid dis-
persion-protein complexes. Thus, by the presence of these three
lipids, in different proportions, the release of cholesterol from
cells can be modulated.
The plausible cholesterol acceptor in these complexes can
be isolated by sequential ultracentrifugation at d=1.063-1.21 g/ml.
The nature of this fraction have not been characterized and further
experiments are required to confirm and evaluate its role. The aim
of future experiments should include 1) the identification of the
lipid and protein composition in these complexes, 2) the structural
study of the complex, 3) the factors that contribute to the ability
of this complex to promote the release of choelsterol, and 4) by
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comparing with serum lipoproteins the function of the. lipoproteins
may be specualted and tested.
Based on the results obtained in the present study., both the
lipid dispersion-protein complexes and HDL appear to promote the
release of cholesterol from cells by a net removal mechanism. It has
been reported that HDL (Stein and Stein, 1973) can release 30% of
the cellular radioactive cholesterol from cultured cells while LDL
can only cause a 10% release. Thus, it is quite clear that HDL have
a higher ability to lower cellular cholesterol level. If HDL can
produce a similar effect in vivo, this may be an alternate route
to prevent the excess deposition of. cholesterol in the peripheral
tissues in addition to the mechanism mediated by the LDL receptor.
The physiological role of LCAT is not yet understood, but
several facts are reasonably well established (Glomset, 1970
Glomset and Norum, 1973). The enzyme is responsible for forming
the bulk of the serum cholesteryl esters and as a result it may
have an indirect control on the composition and structure of the
serum lipoproteins. By thb. action of LCAT, we have reduced the
cholesterol to cholesteryl ester ratio of HDL in our experiment,
however, this change of HDL composition was ineffective to alter
the lipoprotein's ability to remove cholesterol. These results
suggest that the LCAT reaction has no effect on inducing cholesterol
release.
The present study is by no means completed. Based on the
results presented, further experiments should be planned according
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to the following two points. First, the properties of.the lipid dis-
persion-protein complex or its fractions prepared by sequential
ultracentrifugation must be characterized. It has been reported that
only 5 mole% of cholesteryl ester could be incorporated into phos-
pholipid vesicles and excess ester will separate into mesomorphoic
droplets. Unfortunately, the lowest cholesteryl ester to phospholipid
ratio we used has exceeded this, therefore, the real cholesterol to
cholesteryl ester ratio in our dispersion-complex might not be as
stated. On the other hand, the presence of protein may have solu-
bilized more cholesteryl ester than the maximum 5 mole% and in order
to resolve this question further experiments have to be done to
evaluate the exact composition of our dispersion complexes. Other
than the lipids, the protein moiety needs to be identified. It has
been demonstrated that all apoproteins are present in the d1.21
protein fraction (aloupovic, 1973). Therefore, it is interesting
to identify the nature of the proteins recovered in the different
density fractions.
Second, as indicated in our results, HDL have an ability
to lower the cellular total cholesterol content. Although this
ability has no apparent relationship to the lipoprotein's cholesterol
to cholesteryl ester ratio, nevertheless, any other factor that may
contribute to the ability of HDL to release cholesterol from cells
must be identified in order to further understand the mechanism of
HDL-cell interaction.
LCAT plays a singificant role in promoting the formation of
normal HDL from nascent HDL secreted by the liver (Esienberg and
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and Levy, 1975 Esienberg et al, 1975). Furthermore, it has been
found that normal HDL are absent in LCAT deficient patients (Glomset
and Norum, 1973). Taken together with the data obtained in our study,
it seems likely that in the absence of normal HDL the channeling
of peripherial tissue cholesterol into the blood stream becomes
impossible. As a result, cholesterol accumulation in tissues takes
place leading to further physiological complications.
Under normal physiological state, other lipoproteins and
enzymes are present together with HDL in the blood stream and- inter-
stitial fluid, therefore it is likely that they may participate in the
transport of cholesterol. Answers in this area are undoubtedly im-
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